Closing Thoughts on Pharmacists’ Role in Tardive Dyskinesia Management

In this closing episode, the panel outlines practical steps pharmacists can take to support ongoing tardive dyskinesia monitoring across the care continuum. They recommend starting with comprehensive medication reviews to ensure patient safety, identify drug interactions, and recognize when serotonergic antidepressants may elevate antipsychotic levels or interact with VMAT2 inhibitors. A systematic, periodic approach to these reviews is encouraged for long term patients receiving dopamine receptor antagonists. Panelists also urge pharmacists to practice at the top of their training, noting that stepping beyond comfort zones, pursuing additional experience, and expanding services can improve care for individuals with drug induced movement disorders. They emphasize that developing proficiency in assessments like AIMS and engaging in new responsibilities can meaningfully enhance patient outcomes. The discussion also highlights opportunities for pharmacist led clinics and the potential for systems that help identify patients needing monitoring as ways to strengthen continuity of care.